<header id=014699>
Published Date: 2021-12-05 13:31:13 EST
Subject: PRO/ALL> New in IJID (11): November 2021
Archive Number: 20211205.8700079
</header>
<body id=014699>
NEW IN INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (11): NOVEMBER 2021
***********************************************************************
A ProMED-mail post
http://www.promedmail.org
ProMED-mail is a program of the
International Society for Infectious Diseases
http://www.isid.org

Date: November 2021
Source: IJID [edited]
https://www.ijidonline.com/


Coronavirus (COVID-19) collection
---------------------------------
Reviews
-------
COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control.
Buchy et al.
Int J Infect Dis. 2021;112:300-317
https://doi.org/10.1016/j.ijid.2021.09.045

Clinical
--------
Neutralizing antibodies response to SARS-CoV-2 are persistent 9 months post symptom onset in mild or asymptomatic patients.
Bylicki et al.
Int J Infect Dis. 2021;112:8-12
https://doi.org/10.1016/j.ijid.2021.09.002

High seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya.
Ngere et al.
Int J Infect Dis. 2021;112:25-34
https://doi.org/10.1016/j.ijid.2021.08.062

Evaluation of the efficacy of anticoagulation therapy in reducing mortality in a nationwide cohort of hospitalized patients with coronavirus disease in Japan.
Hara et al.
Int J Infect Dis. 2021;112:111-116
https://doi.org/10.1016/j.ijid.2021.09.014

Five probable factors responsible for COVID associated mucormycosis outbreak in India.
Khaiwal et al.
Int J Infect Dis. 2021;112:278-280
https://doi.org/10.1016/j.ijid.2021.09.057

Diagnostics
-----------
SARS-CoV2 rapid antigen testing in the healthcare sector: A clinical prediction model for identifying false negative results.
Leiner et al.
Int J Infect Dis. 2021;112:117-123
https://doi.org/10.1016/j.ijid.2021.09.008

Evaluation of extraction-free RT-PCR methods for faster and cheaper detection of SARS-CoV-2 using two commercial systems.
Morecchiato et al.
Int J Infect Dis. 2021;112:264-268
https://doi.org/10.1016/j.ijid.2021.09.046

Evaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute.
Lutalo et al.
Int J Infect Dis. 2021;112:281-287
https://doi.org/10.1016/j.ijid.2021.09.020

Treatment
---------
Reactions and COVID-19 disease progression following SARS-CoV-2 monoclonal antibody infusion
Goldin et al.
Int J Infect Dis. 2021;112:73-75
https://doi.org/10.1016/j.ijid.2021.09.007

Steroids and mortality in non-critically ill COVID-19 patients: a propensity score weighted study in a Chilean cohort.
Moreno et al.
Int J Infect Dis. 2021;112:124-129
https://doi.org/10.1016/j.ijid.2021.09.038

Safety and heart rate changes in COVID-19 patients treated with Remdesivir.
Brunetti et al.
Int J Infect Dis. 2021;112:254-257
https://doi.org/10.1016/j.ijid.2021.09.036

Immunity and pathology
----------------------
Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose.
Vicenti et al.
Int J Infect Dis. 2021;112:40-44
https://doi.org/10.1016/j.ijid.2021.08.052

Longitudinal clinico-serological analysis of anti-nucleocapsid and anti-receptor binding domain of spike protein antibodies against SARS-CoV-2.
Deshpande et al.
Int J Infect Dis. 2021;112:103-110
https://doi.org/10.1016/j.ijid.2021.09.024

SARS-CoV-2 in cardiomyocytes.
Finsterer et al.
Int J Infect Dis. 2021;112:195-195
https://doi.org/10.1016/j.ijid.2021.09.032

Mast cell activation symptoms are prevalent in Long-COVID.
Weinstock et al.
Int J Infect Dis. 2021;112:217-226
https://doi.org/10.1016/j.ijid.2021.09.043

SARS-CoV-2 neutralizing antibodies decline after one year and patients with severe COVID-19 pneumonia display a unique cytokine profile.
Vacharathit et al.
Int J Infect Dis. 2021;112:227-234
https://doi.org/10.1016/j.ijid.2021.09.021

Potential recurrence of COVID-19 in a healthcare professional: SARS-CoV-2 genome sequencing confirms contagiousness after re-positivity.
Correia et al.
Int J Infect Dis. 2021;112:318-320
https://doi.org/10.1016/j.ijid.2021.09.035

Vaccines
--------
Impact of scaling up SARS-CoV-2 vaccination on COVID-19 hospitalizations in Spain.
Soriano et al.
Int J Infect Dis. 2021;112:81-88
https://doi.org/10.1016/j.ijid.2021.09.022

COVID vaccination and asthma exacerbation: might there be a link?
Colaneri et al.
Int J Infect Dis. 2021;112:243-246
https://doi.org/10.1016/j.ijid.2021.09.026

Epidemiology
------------
Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in Qatar.
Hasan et al.
Int J Infect Dis. 2021;112:52-54
https://doi.org/10.1016/j.ijid.2021.09.006

SARS-CoV-2 seroprevalence among 7950 health-care workers in the Region of Southern Denmark.
von Huth et al.
Int J Infect Dis. 2021;112:96-102
https://doi.org/10.1016/j.ijid.2021.09.023

Differential pre-pandemic breast milk IgA reactivity against SARS-CoV-2 and circulating human coronaviruses in Ugandan and American mothers.
Egwang et al.
Int J Infect Dis. 2021;112:165-172
https://doi.org/10.1016/j.ijid.2021.09.039

SARS-COV-2 antibody seroprevalence in the general population of Oman: results from four successive nationwide seroepidemiological surveys.
Al Abri et al.
Int J Infect Dis. 2021;112:269-277
https://doi.org/10.1016/j.ijid.2021.09.062

Household transmission of SARS-CoV-2: a prospective observational study in Bosnia and Herzegovina, August to December 2020.
Musa et al.
Int J Infect Dis. 2021;112:352-361
https://doi.org/10.1016/j.ijid.2021.09.063

Public health
-------------
COVID-19 and schools: what is the risk of contagion? The results of an antigen rapid test-based screening campaign in Florence (Italy).
Paoli et al.
Int J Infect Dis. 2021;112:130-135
https://doi.org/10.1016/j.ijid.2021.09.027

Follow-up study on the COVID-19 survivors after one year discharged from hospital.
Zhao et al.
Int J Infect Dis. 2021;112:173-182
https://doi.org/10.1016/j.ijid.2021.09.017

Regional differences in NPI efficacy and recommendations for Africa.
Van Gordon et al.
Int J Infect Dis. 2021;112:235-236
https://doi.org/10.1016/j.ijid.2021.09.044

Severity of self-reported symptoms and psychological burden 6-months after hospital admission for COVID-19: a prospective cohort study.
Eloy et al.
Int J Infect Dis. 2021;112:247-253
https://doi.org/10.1016/j.ijid.2021.09.011


Non-COVID-19 collection
-----------------------
Review
------
Nucleic acid amplification techniques for the detection of Schistosoma mansoni infection in humans and the intermediate snail host: a structured review and meta-analysis of diagnostic accuracy.
Li et al.
Int J Infect Dis. 2021;112:152-164
https://doi.org/10.1016/j.ijid.2021.08.061


Original Reports
----------------
Bacterial infections
--------------------
WarmStart colorimetric loop-mediated isothermal amplification for the one-tube, contamination-free and visualization detection of Shigella flexneri.
Shi et al.
Int J Infect Dis. 2021;112:55-62
https://doi.org/10.1016/j.ijid.2021.09.015

Ceftolozane-tazobactam activity against clinical isolates of Pseudomonas aeruginosa from ICU patients with pneumonia: United States, 2015-2018.
Shortridge et al.
Int J Infect Dis. 2021;112:321-326
https://doi.org/10.1016/j.ijid.2021.09.064

One third of people who inject drugs are at risk of incomplete treatment for Staphylococcus aureus bacteraemia: A retrospective medical record review.
Acheson et al.
Int J Infect Dis. 2021;112:63-65
https://doi.org/10.1016/j.ijid.2021.09.012

Tuberculosis
------------
Interruption of tuberculosis detection and care during the Ebola virus disease epidemic (2014-2015) in Liberia: Time-series analyses for 2013-2017.
Gray et al.
Int J Infect Dis. 2021;112:13-20
https://doi.org/10.1016/j.ijid.2021.08.041

Characterizing the gene mutations associated with resistance to gatifloxacin in Mycobacterium tuberculosis through whole genome sequence.
Bi et al.
Int J Infect Dis. 2021;112:189-194
https://doi.org/10.1016/j.ijid.2021.09.028

Peripheral Blood Monocyte to Lymphocyte Ratio for Prediction of Tuberculous Pleuritis.
Sukson et al.
Int J Infect Dis. 2021;112:212-216
https://doi.org/10.1016/j.ijid.2021.09.033

Constructing confidence: User perspectives on AlereLAM testing for tuberculosis.
Engel et al.
Int J Infect Dis. 2021;112:237-242
https://doi.org/10.1016/j.ijid.2021.09.018

Comparative analysis of five inspection techniques for the application in the diagnosis and treatment of osteoarticular tuberculosis.
Liu et al.
Int J Infect Dis. 2021;112:258-263
https://doi.org/10.1016/j.ijid.2021.09.019

Characterizing the molecular composition and diagnostic potential of _Mycobacterium tuberculosis_ urinary cell-free DNA using next-generation sequencing.
Oreskovic et al.
Int J Infect Dis. 2021;112:330-337
https://doi.org/10.1016/j.ijid.2021.09.042

Viral infections
----------------
Arthralgia resolution rate following chikungunya virus infection.
O'Driscoll et al.
Int J Infect Dis. 2021;112:1-7
https://doi.org/10.1016/j.ijid.2021.08.066

Anal human papillomavirus prevalence and risk factors among men who have sex with men in Vietnam.
Tuan et al.
Int J Infect Dis. 2021;112:136-143
https://doi.org/10.1016/j.ijid.2021.09.016

Survival in influenza virus-related pneumonia by viral subtype: 2016-2020.
Murillo-Zamora et al.
Int J Infect Dis. 2021;112:288-293
https://doi.org/10.1016/j.ijid.2021.09.037

Human papillomavirus detected in sperm of Japanese infertile males affects reproductive parameters.
Kato et al.
Int J Infect Dis. 2021;112:294-299
https://doi.org/10.1016/j.ijid.2021.09.029

Development and Evaluation of Reverse Transcription Loop-Mediated Isothermal Amplification for Rapid and Real-Time Detection of Kyasanur Forest Disease Virus.
Kumar et al.
Int J Infect Dis. 2021;112:346-351
https://doi.org/10.1016/j.ijid.2021.01.041

NS1-based ELISA test efficiently detecting dengue infections without cross reactivity with Zika virus.
Pereira et al.
Int J Infect Dis. 2021;112:202-204
https://doi.org/10.1016/j.ijid.2021.09.009

HIV
---
HIV Viral Load Suppression following Intensive Adherence Counselling among People Living with HIV on Treatment at Military-managed Health Facilities in Uganda.
Kikaire et al.
Int J Infect Dis. 2021;112:45-51
https://doi.org/10.1016/j.ijid.2021.08.057

Stages of pregnancy and HIV affect diagnosis of tuberculosis infection and _Mycobacterium tuberculosis_ (MTB)-induced immune response: Findings from PRACHITi, a cohort study in Pune, India.
Bhosale et al.
Int J Infect Dis. 2021;112:205-211
https://doi.org/10.1016/j.ijid.2021.09.010

Parasitic infections
--------------------
Vision-related quality of life and depression in Brazilian patients with Toxoplasmic Retinochoroiditis.
Arruda et al.
Int J Infect Dis. 2021;112:66-72
https://doi.org/10.1016/j.ijid.2021.08.051

Associations Between Malaria in Pregnancy and Neonatal Neurological Outcomes.
Lawford et al.
Int J Infect Dis. 2021;112:144-151
https://doi.org/10.1016/j.ijid.2021.07.037

Evaluation of mass drug administration for schistosomiasis and soil-transmitted helminths in school-aged children in Bankass, Mali.
Sangare et al.
Int J Infect Dis. 2021;112:196-201
https://doi.org/10.1016/j.ijid.2021.08.063

Novel IL-12RÎ²1 Deficiency Mediated Recurrent Cutaneous Leishmaniasis.
Khattak et al.
Int J Infect Dis. 2021;112:338-345
https://doi.org/10.1016/j.ijid.2021.08.049

Structural insights into global mutations in the ligand-binding domain of VAR2CSA and its implications on placental malaria vaccine.
Gill et al.
Int J Infect Dis. 2021;112:35-39
https://doi.org/10.1016/j.ijid.2021.08.054

Hospital infection control
--------------------------
Evaluation of infection prevention and control training workshops using Kirkpatrick's model.
Savul et al.
Int J Infect Dis. 2021;112:76-80
https://doi.org/10.1016/j.ijid.2021.09.005

Vaccines and vaccine preventable infections
-------------------------------------------
Immunogenicity of 2-dose pre-exposure rabies vaccine co-administered with quadrivalent influenza vaccine in children.
Chantasrisawad et al.
Int J Infect Dis. 2021;112:89-95
https://doi.org/10.1016/j.ijid.2021.09.025

Classification of measles breakthrough cases in an elimination setting using a comprehensive algorithm of laboratory results: why highly sensitive and specific IgM assays are important.
Mercader et al.
Int J Infect Dis. 2021;112:21-24
https://doi.org/10.1016/j.ijid.2021.09.004

Case Reports
------------
Usefulness of Xpert® Carba-R on enrichment broth for the early detection of carbapenemase-producing Enterobacterales.
Girlich et al.
Int J Infect Dis. 2021;112:183-185
https://doi.org/10.1016/j.ijid.2021.09.031

A case of tuberculosis and black-grain eumycetoma co-infection in a non-endemic country: clinical presentation and therapeutic management.
Vu et al.
Int J Infect Dis. 2021;112:186-188
https://doi.org/10.1016/j.ijid.2021.09.040

Human Herpesvirus-6 Myelitis after Chimeric Antigen Receptor T-cell Therapy.
Handley et al.
Int J Infect Dis. 2021;112:327-329
https://doi.org/10.1016/j.ijid.2021.09.061

--
Communicated by:
ProMED
<promed@promedmail.org>
See Also
New in IJID (10): October 2021: 20211107.8699506
New in IJID (09): September 2021: 20211007.8698901
New in IJID (08): August 2021: 20210907.8651803
New in IJID (07): July 2021 20210812.8580841
New in IJID (06): June 2021 20210722.8536790
New in IJID (05): May 2021 20210516.8364910
New in IJID (04): April 2021 120210421.8319851
New in IJID (03): March 2021 20210316.8250191
New in IJID (02): February 2021 20210210.8182520
New in IJID (01): January 2021 20210114.8102611
2020
---
New in IJID (12): December 2020 20201209.8005250
New in IJID (11): November 2020 20201117.7950604
.................................................ep/may/jh
</body>
